Table 5.
6 Months |
12 Months |
|||
β | P Value | β | P Value | |
PANSS | ||||
Baseline PANSS | 0.68 | <.0001 | 0.58 | <.0001 |
Intervention | −1.71 | .42 | 0.95 | .67 |
Bipolar | 4.17 | .10 | −0.30 | .91 |
Nonwhite | −0.41 | .87 | 0.64 | .79 |
Age | 0.06 | .57 | 0.04 | .74 |
No substance use | −1.95 | .41 | 1.49 | .53 |
Site B | 3.07 | .35 | −1.73 | .61 |
Site C | 2.05 | .55 | −8.76 | .02 |
Site D | 1.44 | .60 | 2.74 | .34 |
Positive PANSS | ||||
Baseline PANSS | 0.65 | <.0001 | 0.57 | <.0001 |
Intervention | −1.16 | .18 | −0.28 | .75 |
Bipolar | 0.39 | .70 | 0.75 | .48 |
Nonwhite | −0.88 | .37 | 0.56 | .57 |
Age | −0.02 | .67 | 0.02 | .65 |
No substance use | −0.57 | .56 | 0.30 | .76 |
Site B | 0.24 | .85 | −0.67 | .63 |
Site C | 0.03 | .98 | −2.61 | .07 |
Site D | 1.12 | .31 | 0.56 | .62 |
QWB | ||||
Baseline QWB | 0.51 | <.0001 | 0.63 | <.0001 |
Intervention | −0.01 | .76 | −0.01 | .65 |
Bipolar | −0.03 | .10 | −0.03 | .21 |
Nonwhite | 0.02 | .28 | 0.005 | .79 |
Age | −0.002 | .08 | −0.001 | .25 |
No substance use | 0.02 | .23 | −0.002 | .91 |
Site B | 0.03 | .27 | 0.04 | .10 |
Site C | 0.03 | .31 | 0.06 | .04 |
Site D | 0.05 | .04 | 0.05 | .03 |
CSQ-8 | ||||
Baseline CSQ8 | 0.60 | <.0001 | 0.69 | <.0001 |
Intervention | 1.36 | 0.09 | 0.77 | .39 |
Bipolar | −1.28 | 0.18 | −1.15 | .28 |
Non-White | −0.17 | 0.85 | 1.76 | .08 |
Age | 0.04 | 0.34 | 0.11 | .02 |
No Substance Use | 1.58 | 0.07 | 2.90 | .003 |
Site B | −1.62 | 0.20 | −2.11 | .14 |
Site C | 0.16 | 0.89 | 1.04 | .45 |
Site D | −0.42 | 0.68 | −1.13 | .33 |
Note: PANSS, Positive and Negative Symptom Scales; QWB, Quality of Well-being Scales.